Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

When Adam Rodman was a second-year medical student in the 2000s, he visited the library for a patient whose illness had left ...

Generative AI is revolutionizing various industries by enhancing creativity, automating workflows, and delivering ...

The article analyzes bias in healthcare AI, proposing strategies for mitigation to ensure equitable outcomes and enhance ...

A patient with a rare illness would have died if it weren't for AI-powered drug repurposing: When side effects come to the ...

Ignota Labs is using AI to fix failed drugs and bring them to market. It raised $6.9 million from investors with this pitch ...

During a health-focused event in New York on Tuesday, Google announced the development of a new collection of “open” AI ...

Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by identifying an existing drug with the potential to prevent deadly heart ...

Exscientia has advanced a drug candidate for Alzheimer's disease into human testing, the third clinical-stage project for the UK specialist in artificial intelligence (AI) based drug discovery.

Exscientia has signed up another big pharma partner for its artificial intelligence (AI) based drug discovery platform, this time attracting a $50 million upfront buy-in from Bristol-Myers Squibb.